HUMACYTE INC (HUMA) Stock Income Statement
NASDAQ:HUMA - Nasdaq - US44486Q1031 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 1.57M | 1.26M | 1.49M | |||
| Cost Of Goods | N/A | N/A | N/A | 180.00K | N/A | |||
| Gross Profit | N/A | N/A | N/A | 1.09M | N/A | |||
| Operating Expenses | 112.49M | 100.05M | 86.14M | 82.47M | 66.09M | |||
| Research and Development | 88.12M | 76.55M | 63.26M | 61.34M | 54.08M | |||
| Selling, General, and Administrative Expenses | 24.37M | 23.50M | 22.88M | 21.13M | 12.01M | |||
| Operating Income | -112.49M | -100.05M | -84.58M | -81.20M | -64.60M | |||
| Interest Income/Expense | -3.38M | -1.39M | -3.57M | -4.33M | -1.92M | |||
| Other Income/Expense | -36.99M | -10.02M | 76.18M | 55.78M | -320.00K | |||
| Non Recurring Items | N/A | 686.00K | 0.00 | 3.28M | 0.00 | |||
| Income Before Taxes | -152.87M | -110.78M | -11.97M | -26.48M | -66.52M | |||
| Net Income | -152.87M | -110.78M | -11.97M | -26.48M | -66.52M | |||
| EBITDA | -105.28M | -92.33M | -76.37M | -72.96M | -56.25M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.34 | -1.07 | -0.12 | -0.26 | -0.65 | |||
| Non GAAP EPS | -1.34 | -1.07 | -0.13 | -0.51 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | 86.51% | N/A | |||
| Profit Margin | N/A | N/A | -762.42% | -2101.59% | -4464.43% | |||
| Operating Profit Margin | N/A | N/A | -5387.26% | -6444.44% | -4335.57% | |||
All data in USD